Dotti Patch, Extended Release
Product Images NDC 72162-2034

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Dotti (NDC 72162-2034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Dotti Estradiol Transdermal System 1)

FDA Label Image

4a (Dotti Estradiol Transdermal System 10)

FDA Label Image

4b (Dotti Estradiol Transdermal System 11)

FDA Label Image

4c (Dotti Estradiol Transdermal System 12)

FDA Label Image

4d (Dotti Estradiol Transdermal System 13)

FDA Label Image

4e (Dotti Estradiol Transdermal System 14)

FDA Label Image

4f (Dotti Estradiol Transdermal System 15)

FDA Label Image

4g (Dotti Estradiol Transdermal System 16)

FDA Label Image

2 (Dotti Estradiol Transdermal System 2)

FDA Label Image

Figure 1 (Dotti Estradiol Transdermal System 3)

FDA Label Image

2 (Dotti Estradiol Transdermal System 4)

This appears to be a mixture of numerical and textual data, including some medical terminology such as "Estradiol" and "placebo". The text also includes a statement about the statistical significance of a difference between these two treatments. However, there is not enough information to provide a full description of the context or purpose of this data.*

FDA Label Image

2 (Dotti Estradiol Transdermal System 5)

This document appears to be a chart or table showing the percentage change from baseline of different treatments involving estradiol at various doses. The treatments were administered over the course of several weeks, with some lasting up to 104 weeks. Additionally, one of the treatments involved a placebo. The text also includes some apparent errors or typos.*

FDA Label Image

1 (Dotti Estradiol Transdermal System 6)

This appears to be a report of a study, with different treatments being administered and monitored over a duration of 104 weeks in four week intervals. The treatments include different dosages of Estradiol and Placebo. The "ABCVSP", "ABCDwsP", "ABCOWP" and "AvsP" may represent specific treatment groups or measurement categories. The "BN lLoanmnwroo~" may represent some kind of percentage change from baseline measurement.*

FDA Label Image

1 (Dotti Estradiol Transdermal System 7)

DOTTI™ is a transdermal system for estradiol medication. The product comes with specific instructions indicating the days on which the patch should be changed, including Sun/Wed, Mon/Thu, Tue/Fri, Wed/Sat, Thu/Sun, Fri/Mon, and Sat/Tue.*

FDA Label Image

2 (Dotti Estradiol Transdermal System 8)

FDA Label Image

3 (Dotti Estradiol Transdermal System 9)

FDA Label Image

Label (Lbl721622034)

This transdermal system contains 0.627mg N DC 72 1 62_2034_2 of estradiol transdermal for use only as directed. It should be stored at 20° to 25°C (68° to 77°F), but excursions permitted between 15° to 30°C (59° to 86°F) are allowed. This medication should be kept out of reach of children and applied immediately after removal from the pouch. The packaging is not child-resistant. This product was relabeled by Bryant Ranch Prepack, Inc. and manufactured by Amneal Pharmaceuticals.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.